drugset / Trial / NCT00002589
Lymphocyte Therapy in Treating Patients With Kidney Cancer
Treatment
Summary
RATIONALE: Treating a person's lymphocytes with interleukin-2 and monoclonal antibody may help them kill more cancer cells when they are put back in the body. PURPOSE: This phase II trial is studying how well lymphocyte therapy works in treating patients with stage III or stage IV kidney cancer.
Timeline
- Start
- 1994-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | therapeutic autologous lymphocytes | Cell therapy | — | — |
| Background | OKT3 | Monoclonal antibody | — | — |
| Background | aldesleukin | Protein / enzyme biologic | — | — |